|
Match
|
Document |
Document Title |
|
|
US20090291140 |
TREATMENT OF DYSMENORRHEA VIA TRANSDERMAL ADMINISTRATION OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS
Methods and compositions are provided for the treatment of a subject suffering from dysmenorrhea, including both primary and second dysmenorrhea. Aspects of the invention include transdermally...
|
|
|
US20090291139 |
SPARC AND METHODS OF USE THEREOF
The invention provides methods for predicting or determining the response of a mammalian tumor to a chemotherapeutic agent and for treating a mammalian tumor comprising detecting and quantifying...
|
|
|
US20090291137 |
Solid oral form provided with a double release profile
The present invention relates to a solid form, intended for the administration by oral route of at least one active ingredient and capable of guaranteeing a double release mechanism of said active...
|
|
|
US20090291122 |
Wound Care Treatment Product
The invention relates to a wound care treatment product on the basis of honey, wherein the wound care treatment product comprises raw, non-heated honey and an ozonated oil.
|
|
|
US20090291115 |
Superporous hydrogel with cells encapsulated therein and method for producing the same
The present invention is a superporous hydrogel with cells encapsulated within the hydrogel matrix, and a method for producing the same.
|
|
|
US20090285893 |
TREATMENT OF HEART FAILURE IN WOMEN
A method is disclosed utilizing an androgen such as testosterone and/or a selective androgen receptor modulator for treating or delaying the further development of heart failure, and other...
|
|
|
US20090285892 |
METHODS AND SYSTEMS FOR EXPANDING AC133+ CELLS AND DIRECTING DIFFERENTIATION
The invention provides, among other things, methods and systems for expanding CD133+ cells. The invention further provides methods and systems for increasing the blood flow to an ischemic tissue in...
|
|
|
US20090285891 |
Pharmaceutical preparation for oral administration with controlled active ingredient release in the small intestine and method for its production
Any pharmaceutical preparation for oral administration with controlled release of active ingredient in the small bowel, on the basis of active ingredient carriers provided with at least one active...
|
|
|
US20090285890 |
ANTIMICROBIAL PEROXIDASE COMPOSITIONS
The present invention discloses a class of compounds which have an enhancing effect on peroxidase based antimicrobial compositions. The invention relates to pharmaceutical compositions for...
|
|
|
US20090280183 |
MULTIPARTICULATE FORM OF ADMINISTRATION, COMPRISING NUCLEIC ACID-CONTAINING MUCOADHESIVE ACTIVE INGREDIENTS, AND METHOD FOR PRODUCING SAID FORM OF ADMINISTRATION
The invention relates to an oral, multiparticulate form of administration, comprising pellets in the size ranging from 50 to 2500 $g(m)m which are substantially constituted of a) an inner matrix...
|
|
|
US20090280181 |
DELIVERY OF NUCLEIC ACID COMPLEXES FROM PARTICLES
Embodiments of the invention include particles with nucleic acid complexes, medical devices including the same and related methods. In an embodiment, the invention can include a method of making a...
|
|
|
US20090280180 |
COLLAGEN-BASED MATRICES WITH STEM CELLS
Collagen based-matrices and methods of their use are described. More particularly, collagen-based matrices for differentiating stem cells and progenitor cells, and for producing and isolating blood...
|
|
|
US20090280179 |
Resorbable Calcium Phosphate Based Biopolymer-Cross-Linked Bone Replacement Material
A resorbable bone replacement material made of calcium phosphate particles of different phases which are embedded in an inventive-specific cross-linked collagen matrix. The goal is to form a...
|
|
|
US20090274761 |
TRANSDERMAL DELIVERY OF (R)-3,3-DIPHENYLPROPYLAMIN-MONOESTERN
The invention relates to a device for transdermally administering a compound of formula (I), wherein A represents hydrogen or deuterium, R represents a group selected among C 1-4 alkyl, C 3-10...
|
|
|
US20090274760 |
Use of An Alkyl Glycoside Or Of A Mixture Of Alkyl Glycosides Having Anti-Ageing And/Or Calming Properties As Active Agents In Cosmetic Compositions, And Methods Of Cosmetic Care Using Said Compositions
The present invention relates to a novel use of alkyl glycosides and of mixtures of alkyl glycosides having anti-ageing and/or calming properties as active agents in cosmetic compositions, and to...
|
|
|
US20090274759 |
SOLID PHARMACEUTICAL COMPOSITION WITH A FIRST FRACTION OF A DISPERSION MEDIUM AND A SECOND FRACTION OF A MATRIX, THE LATTER BEING AT LEAST PARTIALLY FIRST EXPOSED TO GASTROINTESTINAL FLUIDS
A solid pharmaceutical composition in the form of a single dosage unit for oral use, the composition comprising a first and a second fraction, the first fraction comprises a therapeutically and/or...
|
|
|
US20090274758 |
Solid Composition for Intra-Oral Delivery of Insulin
The invention provides a solid composition for intra-oral delivery of insulin, comprising; insulin; a hydrophilic polymer matrix; and a phospholipid, providing insulin bioavailability of at least 5%.
|
|
|
US20090274746 |
METHODS AND COMPOSITIONS FOR CONTROLLED DELIVERY OF PHYTOCHEMICAL AGENTS
The presently-disclosed subject matter provides compositions and methods for treating a cancer by providing a composition comprising a biocompatible polymeric matrix incorporating an effective...
|
|
|
US20090269406 |
Therapeutic uses of biocompatible biogel compositions
The present invention relates to biocompatible biogel compositions and methods of drug delivery. The biocompatible biogel is a physical polymer matrix formed via affinity interactions between its...
|
|
|
US20090269405 |
ENZYME MEDIATED DELIVERY SYSTEM
The present invention includes compositions, methods, and systems for the development of a novel delivery vehicle that affects release of an agent upon the degradation of components of said vehicle...
|
|
|
US20090269404 |
Crosslinked Gelatin Gel, Multilayered Structure, Carrier for Bioactive Factor, Preparation for Release of Bioactive Factor, and Their Production Methods
A multi-layer crosslinked gelatin gel structure having a layer structure that plural layers of crosslinked gelatin gel crosslinked by irradiating gelatin or a gelatin derivative with electron beam...
|
|
|
US20090269400 |
Nanoparticulate and Controlled Release Compositions Comprising a Cephalosporin
The present invention is directed to compositions comprising a nanoparticulate antibiotic having improved bioavailability. Preferably, the antibiotic comprises nanoparticulate cephalosporin...
|
|
|
US20090263483 |
NANOPARTICLE FORMULATIONS AND USES THEREOF
The present invention provides compositions comprising nanoparticles comprising: 1) a drug, such as a hydrophobic drug derivative; and 2) a carrier protein. Also provided are methods of treating...
|
|
|
US20090263319 |
METHODS AND COMPOSITIONS FOR TREATING POSTOPERATIVE PAIN COMPROSING KETOROLAC
Methods and compositions are provided for reducing, treating or preventing postoperative pain or inflammation in a patient in need of such treatment, the methods and compositions comprising...
|
|
|
US20090258062 |
Transdermal Therapeutic System Comprising Active Ingredient Particles and Having Increased Active Ingredient Flux
The invention relates to a transdermal therapeutic system, preferably a transdermal patch, having an active ingredient-containing matrix formed substantially of a water-insoluble base material,...
|
|
|
US20090252797 |
TOPICAL APPLICATION OF IVERMECTIN FOR THE TREATMENT OF DERMATOLOGICAL CONDITIONS/AFFLICTIONS
Dermatological conditions/afflictions such as rosacea, common acne, seborrheic dermatitis, perioral dermatitis, acneform rashes, transient acantholytic dermatosis, and acne necrotica miliaris, most...
|
|
|
US20090252796 |
NUTRITIONAL SUPPLEMENT FOR THE PREVENTION OF CARDIOVASCULAR DISEASE, ALZHEIMER'S DISEASE, DIABETES, AND REGULATION AND REDUCTION OF BLOOD SUGAR AND INSULIN RESISTANCE
A mixture (which may be utilized as a food or a drink or a supplement or a drug or a cosmetic or a hygienic product) that is formulated and is capable of improving a person's well being, lowering...
|
|
|
US20090252795 |
Bioceramic scaffolds for tissue engineering
This invention relates to bioinert microporous bioceramic scaffolding, matrices or spheres comprising a particulate microporous bioinert ceramic material, which is a primary structure, and in the...
|
|
|
US20090252773 |
EMULSION COMPOSITION
An emulsion composition of the present invention includes (A) a salt of a higher fatty acid ester of ascorbic acid-2-phosphoric acid ester, (B) a polyglycerin fatty acid monoester including...
|
|
|
US20090246279 |
PARTICLES HAVING HYDROPHOBIC MATERIAL THEREIN
A process for preparing particles having a hydrophobic material therein is disclosed. The process comprises providing a multiple emulsion comprising a first emulsion dispersed in a hydrophobic...
|
|
|
US20090246278 |
USE OF ESSENTIAL OILS TO REDUCE BENZODIAZEPINE REQUIREMENTS DURING MEDICAL PROCEDURES
A method to reduce or eliminate the need for medicaments such as benzodiazepine and narcotics in noxious medical procedures, such as intravenous needle insertion, mechanical ventilation and...
|
|
|
US20090246274 |
PHARMACEUTICAL COMPOSITION 271
The invention concerns pharmaceutical compositions containing a hydrogen sulphate salt of 6-(4-bromo-2-chloro-phenylamino)-7-fluoro-3-methyl-3H-benzoi
midazole-5-carboxylic acid...
|
|
|
US20090246256 |
Compositions and Methods for Transmucosal Delivery of Lofexidine
The present invention provides for compositions and methods for accelerating the rate of delivery of lofexidine to the systemic circulation by transmucosal administration through the nasal,...
|
|
|
US20090238873 |
EXTENDED RELEASE FORMULATION CONTAINING A WAX
Extended release pharmaceutical formulations are disclosed wherein the formulations contain an extended release portion and an immediate release portion, the extended release portion comprising an...
|
|
|
US20090238872 |
Chlorine dioxide releasing composite article
A composite article that includes a ClO 2 -producing material integrated into an organic matrix and methods of using the same are described. The organic matrix of the composite article is formable...
|
|
|
US20090232891 |
Cell Transport Compositions and Uses Thereof
Compositions and methods have been developed for transporting compounds across membranes with little or no toxicity and, when targeted through the appropriate routes of administration (i.e., lung,...
|
|
|
US20090232890 |
COMPOSITIONS AND METHODS FOR DISTRACTION OSTEOGENESIS
The present invention relates to compositions and methods for use in osteodistraction procedures. In one embodiment, a method of stimulating osteogenesis during and/or following bone distraction...
|
|
|
US20090226522 |
PROCESS TO MINIMIZE POLYMORPHISM
The commercial formulation of fast dispersing dosage forms (FDDF) requires substantial holding times during which large quantities of pharmaceutically active substance are formed into individual...
|
|
|
US20090226521 |
Active nanoparticles and method of using
Active multifunctional nanoparticles provide significant enhancement of the efficacy of model therapeutic and gene agents due to increased diffusion and penetration through mucus and biological...
|
|
|
US20090226520 |
Medical composition employing nanostructures
A composition of microscopic devices utilizable in a medical diagnostic or therapeutic procedure. Each microscopic device includes a nanostructure provided with a ligand for effectively coupling...
|
|
|
US20090226519 |
Hydrogel bioscaffoldings and biomedical device coatings
Bioscaffoldings formed of hydrogels that are crosslinked in situ in an infarcted region of the heart (myocardium) by a Michael's addition reaction or by a disulfide bond formed by an oxidative...
|
|
|
US20090226507 |
HYDROXIDE-RELEASING AGENTS AS SKIN PERMEATION ENHANCERS
A method is provided for increasing the permeability of skin or mucosal tissue to topically or transdermally administered pharmacologically or cosmeceutically active agents. The method involves use...
|
|
|
US20090220605 |
BONE MATRIX COMPOSITIONS HAVING NANOSCALE TEXTURED SURFACES
Bone matrix compositions having nanoscale textured surfaces and methods for their production are provided. In some embodiments, bone matrix is prepared for implantation and retains nanoscale...
|
|
|
US20090220603 |
USE OF RHAMNOLIPIDS IN WOUND HEALING, TREATING BURN SHOCK, ATHEROSCLEROSIS, ORGAN TRANSPLANTS, DEPRESSION, SCHIZOPHRENIA AND COSMETICS
Various methods are provided, including wound healing with reduced fibrosis, treatment of burn shock, treatment and prevention of atherosclerosis, prevention and treatment of organ transplant...
|
|
|
US20090220602 |
SUBLIMABLE SUSTAINED RELEASE DELIVERY SYSTEM AND METHOD OF MAKING SAME
The invention relates to compositions suitable for the delivery and/or stabilization of biologically active substances. The compositions comprise a sublimable matrix material and the biologically...
|
|
|
US20090220601 |
Autologous Oral Grafts
The present invention provides autologous oral grafts that may be used, for example, to treat oral cavity disease characterized by inflamed or damaged oral mucosa tissue, or to treat oral caries...
|
|
|
US20090220600 |
ANTIMICROBIAL FILMS
A film consisting of a titanium dioxide host matrix comprising silver oxide nanoparticles.
|
|
|
US20090220596 |
Composition and Dosage Form Comprising a Solid or Semi-Solid Matrix
A composition which comprises a solid or semi-solid matrix having at least one active ingredient uniformly dispersed therein, the matrix comprising at least one pharmaceutically acceptable...
|
|
|
US20090220575 |
COMPOSITIONS AND METHODS FOR THE SUSTAINED RELEASE OF BETA-ALANINE
Methods and compositions are provided for increasing the anaerobic working capacity of muscle and other tissues. Also provided are compositions formulated for the sustained release of free...
|
|
|
US20090220572 |
Injectable Combination Therapy for Eye Disorders
The present invention provides composition, methods, and articles of manufacture for treating an eye disorder, e.g., a disorder characterized by macular degeneration, choroidal neovascularization,...
|